@article {Okada968, author = {A A Okada and T Wakabayashi and Y Morimura and S Kawahara and E Kojima and Y Asano and T Hida}, title = {Trans-Tenon{\textquoteright}s retrobulbar triamcinolone infusion for the treatment of uveitis}, volume = {87}, number = {8}, pages = {968--971}, year = {2003}, doi = {10.1136/bjo.87.8.968}, publisher = {BMJ Publishing Group Ltd}, abstract = {Aim: To assess efficacy and complications of trans-Tenon{\textquoteright}s retrobulbar infusion of triamcinolone acetonide for posterior uveitic inflammation. Methods: Non-randomised, uncontrolled, retrospective study of 51 eyes of 37 patients who underwent triamcinolone infusion for vitritis, cystoid macular oedema (CMO), or posterior retinal vasculitis using a long blunt cannula via an incision made through conjunctiva and Tenon{\textquoteright}s capsule. Results: Overall clinical efficacy was 86\%; 96\% for vitritis, 82\% for CMO, and 33\% for posterior retinal vasculitis. Mean visual acuity improved within 1 month after triamcinolone infusion (p \<0.05). Cataract progression and intraocular pressure elevation were observed in 31\% and 27\% of eyes, respectively. Conclusion: Trans-Tenon{\textquoteright}s retrobulbar triamcinolone infusion may be a safe and effective treatment for posterior uveitic inflammation.}, issn = {0007-1161}, URL = {https://bjo.bmj.com/content/87/8/968}, eprint = {https://bjo.bmj.com/content/87/8/968.full.pdf}, journal = {British Journal of Ophthalmology} }